PBI Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Pitney Bowes Inc. does not present a strong buy opportunity for a beginner investor with a long-term strategy at this time. While there are positive developments in earnings estimates and analyst upgrades, the lack of strong proprietary trading signals, insider and hedge fund selling, and technical indicators showing potential short-term downside suggest waiting for a more favorable entry point.
The stock shows bullish moving averages (SMA_5 > SMA_20 > SMA_200), but the MACD is negatively expanding, and RSI is neutral at 71.895. Key resistance levels are at 17.645 and 18.025, while support levels are at 16.415 and 16.035. The stock has a 60% chance of declining in the next day (-0.11%), week (-0.84%), and month (-3.76%).
Analysts have raised price targets recently, with Citizens increasing it to $19 citing positive developments.
Earnings estimates have increased by 11% over the last 60 days.
The company's PEG ratio of 0.75 indicates valuation advantages compared to industry averages.
Hedge funds and insiders are significantly increasing their selling activity, with insider selling up 1209.72% in the last month.
The MACD is negatively expanding, and short-term stock trends suggest potential declines.
No proprietary trading signals (AI Stock Picker or SwingMax) are present to support a buy decision.
No detailed financial data available for analysis. However, analysts note improving revenue stabilization and cost control measures.
Analysts have been upgrading the stock, with price targets raised by Citizens ($19), BofA ($16.50), and Goldman Sachs ($15.20). The upgrades are based on improved earnings, cost reductions, and stabilizing revenue trends. However, some analysts maintain a Neutral or Hold rating, reflecting cautious optimism.
